Table 1 Demographics and clinical characteristics of participants

From: Gyroscopic wearable improves balance performance in people with degenerative ataxia – a sham-controlled robotics study

Number of participants

14

Age (years)

57 (±7)

Sex (female)

2

Weight (kg)

89 (±15)

Height (cm)

185 (±11)

Diagnosis (number of participants)

 

Clinical

ILOCA

1

ADCA, no genotype

2

CANVAS, no genotype

1

Molecular

SCA-1

4

SCA-3

3

SCA-6

1

SCA-14

1

SCA-28

1

Disease duration (years)

16 [4–52]

Activities-specific Balance Confidence Scale (%)

55 [42–96]

Scale for the Assessment and Rating of Ataxia (points)

12 [7–20]

Mini-Balance Evaluation Systems Test (points)

14 [4–25]

  1. Values displayed are means (±SD) or median [range]. SCA Spinocerebellar ataxia, ILOCA Idiopathic late-onset cerebellar ataxia, ADCA Autosomal dominant cerebellar ataxia, CANVAS Cerebellar ataxia, neuropathy and vestibular areflexia syndrome. Activities-specific Balance Confidence Scale (ABC) ranges between 0–100%; higher scores indicate higher confidence. Scale for the Assessment and Rating of Ataxia (SARA) ranges from 0–40; higher scores indicate higher disease severity. Mini Balance Evaluation Systems Test (Mini-BESTest) ranges from 0–28 points; higher scores indicate better balance capacity.
Back to article page